968
A. A. Aly, T. E. Malah, E. A. Ishak, A. B. Brown, and W. M. Elayat
Vol 53
(dd, 2H, J = 8.0, 1.0 Hz, Ar–H), 8.10–8.15 (d, 1H, J = 1.2 Hz,
naphth–H). 13C-NMR: δ = 156.8, 156.0 (C═N), 153.0 (Ar–C–
OCH3), 145.0 (naphth–C–2), 135.6, 133.8 (naphth–C), 129.8
(Ar–2CH–m), 128.6 (naphth–2CH), 127.2 (naphth–CH), 126.9
(naphth–2CH), 124.0 (Ar–CH), 122.0 (naphth–CH), 119.0
(naphth–CH–1), 116.8 (Ar–2CH–o), 57.8 (OCH3). Calcd. for
C19H14N2O2S (334.39): C, 68.24; H, 4.22; N, 8.38; S, 9.59.
Found: C, 68.48; H, 4.10; N, 8.12; S, 9.70%.
Reaction of thiosemicarbazone 12 with AETC, 13. To a
stirred solution of thiosemicarbazone (12,0.179g, 1 mmol) in
nearly 30mL of 1,4-dioxane together with two drops of
piperidine, a solution of 13 (0.118 g, 1 mmoL) was added
dropwise in 30 min. The reaction was then refluxed for 4 h
and the precipitate formed was filtered off and recrystallized
from EtOH.
4-Amino-3-(benzylidene-amino)-2-imino-2,3-dihydrothiazole-
5-carbonitrile (15). Yellow crystals (methanol), yield (0.206 g,
85%), mp 182–184°C. IR: ν = 3340–3325 (NH2–NH, m), 2220
N-(5-Naphthalen-1-yl)-3H-1,2,4-oxathiazol-3-ylidene)aniline
(3c).
Brown crystals (EtOH), (0.64 g, 70%); mp 260–262°C.
IR: ν = 3060–3040 (w, Ar–CH), 1560 (s, C═C) cmÀ1. H-NMR:
δ = 6.86–6.90 (dd, 2H, J = 8.0, 1.0 Hz, Ph–H–o), 7.10–7.14 (m,
1H, Ph–p), 7.36–7.40 (dd, 2H, J = 8.0, 1.0 Hz, Ph–m), 7.60–7.64
(m, 2H, naphth–H), 8.10–8.30 (m, 4H, naphth–H), 8.25–8.27 (d,
1H, J = 8.0, 1.0 Hz, naphth–H–1). 13C-NMR: δ = 160.0, 158.2
(C═N), 145.0 (Ph–C), 135.4, 134.0 (naphth–C), 131.0 (Ph–2CH–
m), 128.3 (naphth–C), 128.0 (naphth–2CH), 127.8 (naphth–CH),
126.6 (Ph–CH–p), 126.4 (naphth–2CH), 122.6 (naphth–CH),
119.2 (naphth–CH), 122.8 (Ph–2CH–o). Calcd. for C18H12N2OS
(304.07): C, 71.03; H, 3.97; N, 9.20; S, 10.54. Found: C, 70.88;
H, 4.10; N, 9.10; S, 10.50%.
(CN, s), 1600 (C═N, s), 1560 (C═C, m) cmÀ1 1H-NMR:
.
1
δ = 10.50 (br, s, 1H, NH), 8.20 (s, 1H, CH═N), 7.10–6.80
(m, 7H, Ph–H, NH2). 13C-NMR: δ = 178.0 (C-5), 156.0
(C═NH), 154.0 (CH═N), 132.0 (Ph–C), 128.0 (Ph–2CH–o),
127.2 (Ph–2CH–m), 126.0 (Ph–CH–p), 116.0 (CN), 78.0
(C-4). Calcd. for C11H9N5S: C, 54.31; H, 3.73; N, 28.79. Found:
C, 54.44; H, 3.78; N, 28.66%.
Reaction of 1,1-dimethylthiourea (16) with AETC, 13. To
a stirred solution of 16 (0.104 g, 1 mmol) in nearly 20 mL of 1,4-
dioxane together with two drops of piperidine, a solution of 13
(0.118 g, 1 mmoL) was added dropwise in 30 min. The reaction
was then refluxed for 10 h. The reaction was cooled and the
precipitate was extracted with CHCl3. The solvent was
evaporated in vacuum and formed; the precipitate was filtered
off and recrystallized from CHCl3/EtOH.
4-Chloro-N-(5-naphthalen-1-yl)-3H-1,2,4-oxathiazol-3-ylidene)
aniline (3d). Pale red crystals (CHCl3/MeOH), (0.70 g, 69%); mp
200–202°C. IR: ν = 3068–3050 (w, Ar–CH), 1565 (s, C═C).
1H-NMR: δ = 6.92–6.95 (dd, 2H, J = 7.8, 1.0 Hz, Ph–o),
7.40–7.44 (dd, 2H, J = 8.0, 1.0 Hz, Ph–m), 7.58–7.62 (m,
2H, naphth–H), 8.08–8.22 (m, 4H, naphth–H), 8.40–8.43
(dd, 1H, J = 7.8, 1.0 Hz naphth–CH–1). 13C-NMR: δ = 160.4,
158.6 (C═N), 145.8 (Ph–C), 136.0, 134.8 (naphth–C), 132.0
(Ph–C–Cl), 130.4 (Ph–2CH–m), 128.2 (naphth–C), 128.0
(naphth–CH), 127.8 (naphth–2CH), 127.6 (naphth–CH),
126.6 (naphth–2CH), 122.4 (naphth–CH), 122.8 (Ph–2CH–o), 119.4
(naphth–CH–1). Calcd. for C18H11ClN2OS (338.81): C, 63.81; H,
3.27; N, 8.27; S, 9.46. Found: C, 63.70; H, 3.15; N, 8.20; S, 9.40%.
2-Methoxy-N-(5-naphthalen-1-yl)-3H-1,2,4-oxathiazol-3-ylidene)
aniline (3e). Pale red crystals (ethyl acetate), (0.75 g, 75%); mp
140–142°C. IR: ν = 3090–3050 (w, Ar–CH), 2950–2840
2-Amino-2-imino-N,N-dimethylethanethioamide (19). Brown
crystals (CHCl3/EtOH), yield (0.112 g, 85%), mp 260–262°C. IR:
ν = 3320–3250 (NH2–NH, m), 1600 (C═N, s) cmÀ1
.
1H-
NMR: Table 1. 13C-NMR: Table 1. MS (EI) 131 (100), 116
(67), 97 (12), 89 (10). Calcd. for C4H9N3S: C, 36.62; H,
6.91; N, 32.03. Found: C, 54.44; H, 6.80; N, 31.88%.
Material and methods for antioxidant activity [14]. The
antioxidant activity of each organic compound was measured
alone.
Preparation of CUPRAC assay solution.
CuCl2 solution,
1.0 × 10À2 M was prepared by dissolving 0.426 g CuCl2.2H2O
in water and diluting to 0.250 mL. Ammonium acetate buffer at
pH 7, 1.0 M, was prepared by dissolving 19.27 g NH4AC in
water and diluting to 250 mL. Neocuproine (Nc) solution,
7.5 × 10À3 M, was prepared by dissolving 0.039 g Nc in 96%
ethanol and diluting to 25 mL with ethanol.
(w, aliph.–CH), 1560 (s, C═C) cmÀ1 1H-NMR: δ = 3.92
.
(s, 3H, OCH3), 6.70–6.73 (dd, 1H, J = 7.8, 1.0 Hz|, Ph–H),
7.00–7.30 (m, 3H, Ph–H), 7.40–7.60 (m, 4H, naphth–H), 8.10–8.22
(m, 2H, naphth–H), 8.40–8.43 (dd, 1H, J= 7.8, 1.0 Hz, naphth–H).
13C-NMR: δ = 160.0, 158.0 (C═N), 153.2 (Ph–C–OCH3), 136.2,
135.0 (naphth–C), 134.2 (Ph–C), 130.2 (Ph–CH), 128.4
(naphth–2CH), 128.2 (Ph–CH), 128.0 (naphth–C), 127.0 (Ph–CH),
127.4 (naphth–2CH), 127.0, 125.8, 122.4 (naphth–CH), 120.2
(Ph–CH), 55.0 (OCH3). Calcd. for C19H14N2O2S (334.39):
C, 68.24; H, 4.22; N, 8.38; S, 9.59. Found: C, 68.36; H, 4.30;
N, 8.24; S, 9.40%.
Preparation of standard solution of ascorbic acid
antioxidant. The standard solution of ascorbic acid antioxidant
was prepared at 1.0 × 10À3 M concentration by dissolving ascorbic
acid in water.
Serum extraction and preparation for total antioxidant
CUPRAC assay. Freshly collected serum samples were kept
at +4°C until just prior to analysis. About 1 mL of serum was
transferred to centrifuge tube, 2 mL of 96% ethanol, and 1 mL
of distilled water were added and mixed well. About 4 mL
of n-hexane were added to the mixture and mixed again, and
the final mixture was allowed to stand for a few minutes for
separation of the phases. The solution was separated using
centrifuging technique at 1500 g (5000 rpm) for 5 min. The
upper organic phase was separated and transferred to a dark
tube. The hexane extraction procedure was repeated and the
second hexane extracted was separated and then transferred to
the original dark tube so as to combine with the first extract.
The combined hexane extracts were dried under N2 flow, and
the residue was taken up in 1 mL of dichloromethane for assay
of trichloroacetic acid (TCA)-Protein method.
Reaction of thiosemicarbazide 7 with 2.
To a stirred
solution of thiosemicarbazide (7, 0.273 g, 3 mmol) in 50 mL of
1,4-dioxane together with two drops of piperidine, a solution of
2 (0.384 g, 3 mmoL) was added dropwise in 10 min. The
reaction was then refluxed for 6 h and the precipitate formed
was filtered off and recrystallized from EtOH.
Dicyano-5-imino-2,5-dihydro-1H-pyrazole-1-carbothioamide
(10). Red crystals (0.48 g, 82%); mp 134–136°C. IR: ν = 3360–
3300 (m, NH2, NH), 2220 (s, CN), 1560 (s, C═C) cmÀ1
.
1H-NMR: δ = 10.4 (s, 2H, NH–thioamido), 6.6 (s, 2H, NH2).
13C-NMR: δ = 178.6 (C═S), 156.2 (C═N, C-5), 134.8 (C-3),
111.2, 113.6 (CN), 78.6 (C-4). Calcd. for C6H4N6S: C,
37.49; H, 2.10; N, 43.73; S, 16.68. Found: C, 37.30; H,
2.08; N, 43.90; S, 16.60%.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet